Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (281-290 of 543) with videos related to

Pageof 55
Sort By:
Gastroenterology|October 10, 1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging studyF Nevens, J Main, P Honkoop, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 27, 2004
The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaireSimone M van der Plas, Bettina E Hansen, Josien B de Boer, et al.
Journal of Viral Hepatitis|January 30, 2009
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeksJ G P Reijnders, W F Leemans, B E Hansen, et al.
BMC Gastroenterology|November 18, 2003
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional studySimone M van der Plas, Bettina E Hansen, Josien B de Boer, et al.
Antiviral Therapy|August 4, 2020
Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis BBoris Jb Beudeker, Zwier Ma Groothuismink, Robert A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]A A van der Eijk, J K Doorduijn, H L A Janssen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2017
Management of hepatic angiomyolipoma: A systematic reviewAnne J Klompenhouwer, Danielle Verver, Shiromani Janki, et al.
The British Journal of Radiology|December 11, 2007
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinomaI C van den Bos, S M Hussain, R S Dwarkasing, et al.
Radiology|August 31, 2011
Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classificationSusanna M van Aalten, Maarten G J Thomeer, Türkan Terkivatan, et al.
The British Journal of Dermatology|August 23, 2003
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infectionM Willems, K Munte, J M Vrolijk, et al.
Pageof 55

Showing results (281-290 of 543) with videos related to

Sort By:
Pageof 55
Gastroenterology|October 10, 1997
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging studyF Nevens, J Main, P Honkoop, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 27, 2004
The Liver Disease Symptom Index 2.0; validation of a disease-specific questionnaireSimone M van der Plas, Bettina E Hansen, Josien B de Boer, et al.
Journal of Viral Hepatitis|January 30, 2009
On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeksJ G P Reijnders, W F Leemans, B E Hansen, et al.
BMC Gastroenterology|November 18, 2003
Generic and disease-specific health related quality of life in non-cirrhotic, cirrhotic and transplanted liver patients: a cross-sectional studySimone M van der Plas, Bettina E Hansen, Josien B de Boer, et al.
Antiviral Therapy|August 4, 2020
Hepatitis B core-related antigen levels predict pegylated interferon-α therapy response in HBeAg-positive chronic hepatitis BBoris Jb Beudeker, Zwier Ma Groothuismink, Robert A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 3, 2002
[Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma]A A van der Eijk, J K Doorduijn, H L A Janssen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2017
Management of hepatic angiomyolipoma: A systematic reviewAnne J Klompenhouwer, Danielle Verver, Shiromani Janki, et al.
The British Journal of Radiology|December 11, 2007
Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinomaI C van den Bos, S M Hussain, R S Dwarkasing, et al.
Radiology|August 31, 2011
Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classificationSusanna M van Aalten, Maarten G J Thomeer, Türkan Terkivatan, et al.
The British Journal of Dermatology|August 23, 2003
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infectionM Willems, K Munte, J M Vrolijk, et al.
Pageof 55